Serum caspase-cleaved fragmented cytokeratin-18(CK-18) reflects the degree of apoptosis and has been shown as an independent predictor in diagnosis of NASH [15–18]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.